Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07261423 · ClinicalTrials.gov registry record · NA
Pollution Intervention to Impact Kids Asthma Study
A NA study of Childhood Asthma and Asthma Control, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 351
- Enrollment target
- 1
- Study location
NCT07261423: Recruiting NA study of Childhood Asthma and Asthma Control, sponsored by University of Pittsburgh.
NCT07261423 is a NA study of Childhood Asthma and Asthma Control that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 351 participants, above the 140-participant average among 4 other Childhood Asthma trials with a reported enrollment target (151% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07261423, a NA study of Childhood Asthma and Asthma Control, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 351 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if adding Air Quality Index (AQI) information to asthma action plans works to improve asthma outcomes in children. It will also learn about children with asthma who report being more sensitive to outdoor air pollution. The main questions it aims to answer are: * Does adding either information about the EPA-AQI or commercial AQI improve asthma outcomes over time? * Are there changes in nasal gene expression in children with asthma who report they are more sensitive to outdoor air pollution? Researchers will compare EPA-AQI and the commercial-AQI groups to a control group to either AQI works to improve asthma. Participants will: * Receive standardized outdoor air pollution education and an asthma action plan * Provide nose and blood specimens * Have visits every 4 weeks for 48 weeks, 10 will be conducted by telephone calls and 3 visits will be in person.
Primary Outcome
Asthma control will be measured via the validated Asthma Control Test (ACT) and Childhood-ACT (CACT). Asthma control will be evaluated at all study visits (Visits 1-13), every 4 weeks. The ACT will be used for children aged 12 -17 years, the CACT will be used for children aged 8-11 years. The ACT is a 5 question instrument with scores from 5-25, with higher scores generally indicating better control. The CACT is a 7 question instrument with scores from 0-27, with higher scores generally indicati
Conditions Studied
Interventions
- BEHAVIORAL EPA-AQI
- BEHAVIORAL Commerical-AQI
- BEHAVIORAL Education and plan
Study Locations (1)
Pennsylvania
- UPMC Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 351 participants |
| Start Date | 2026-02-24 |
| Est. Completion | 2030-01 |
| Phase | NA |
What NCT07261423 shows while recruiting
NCT07261423 is an interventional study that assigns participants to a tested intervention. The registered 351 participants enrollment target is mid-sized for trials with a published cap, above the 140-participant average among 4 other Childhood Asthma trials with a reported enrollment target (151% higher).
The record links to 4 conditions, with Childhood Asthma appearing as the primary indexed condition, and to 3 interventions - of which EPA-AQI is the first listed.
NCT07261423 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07261423 about?
NCT07261423 is a clinical study titled "Pollution Intervention to Impact Kids Asthma Study". The goal of this clinical trial is to learn if adding Air Quality Index (AQI) information to asthma action plans works to improve asthma outcomes in children. It will also learn about children with asthma who report being more sensitive to outdoor air pollution. The main questions it aims to answer ...
What is the current status of trial NCT07261423?
This trial is currently recruiting. It is a NA study. The enrollment target is 351 participants. The study started on 2026-02-24. Estimated completion is 2030-01.
What conditions does trial NCT07261423 study?
This clinical trial studies the following conditions: Childhood Asthma, Asthma Control, Asthma Exacerbation, Air Pollution, Risk Reduction Behaviors.
What interventions are being tested in trial NCT07261423?
The interventions under investigation include: EPA-AQI (BEHAVIORAL), Commerical-AQI (BEHAVIORAL), Education and plan (BEHAVIORAL).
Who is sponsoring clinical trial NCT07261423?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07261423 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Asthma Link Effectiveness Trial
RECRUITING · NA
-
A Community-based Participatory Research (CBPR) Intervention for Childhood Asthma Using Air Filters and Air Conditioners
COMPLETED · NA
-
COPE for Children With Asthma: Intervention for Children With Asthma
COMPLETED · NA
-
Urinary 8-isoprostane is Elevated in Acute Childhood Asthma
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06241456 · 351 participants · Phase 1
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
- NCT06576726 · 351 participants
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
- NCT07043400 · 351 participants · Phase 3
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT05811936 · 352 participants · NA
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI